Achillion Pharmaceuticals (ACHN) Tops Q1 EPS by 5c

Achillion Pharmaceuticals (NASDAQ: ACHN) reported Q1 EPS of ($0.17), $0.05 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Achillion Pharmaceuticals (ACHN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand